Drug Delivery Markets: Oral Delivery

Keywords : drug delivery , oral drug delivery, Drug Delivery Technology, oral delivery, Controlled release

Since our last edition of this report in 2007, The oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderly population that requires products with a level of ease-of-use and cost benefit, it’s no surp...

More »

Since our last edition of this report in 2007, The oral drug delivery market is the largest segment of the drug delivery market, and there’s no sign that it is slowing down. With pharmaceutical companies increasingly turning to drug delivery to extend the revenue-earning lifetime of their biggest products, and seeking to tap into the growing elderly population that requires products with a level of ease-of-use and cost benefit, it’s no surprise that the oral delivery drug market is a $35 billion industry and expected to grow as much as ten percent per year.


Oral Delivery provides the definitive break down of the market for oral delivery drug markets. The report covers both the major technologies in oral delivery (controlled-release, delayed release, pulsatile-release, taste-masked and microemulsion formulations) and the products that use these delivery technologies.



This focused report provides information on the revenues for relevant companies and provides information critical to assessing the opportunities available in this market, including:

• Legacy Companies in Oral Delivery as well as Recent Entrants


• Current World Wide Revenue Across Product Categories and Future Forecasts


• Revenues by Combonent and by Component ( Pharmaceutical vs. Technology portion of Revenue) Type of Delivery (Timed Release vs. Other)


• Challenges Faced by Oral-Delivery Technology Companies


• Success Stories and Pitfalls


• The Trends That are Expected to Lead to Global Growth

Information and analysis presented in this report is based on extensive interviews with senior management of top companies in the industry. While major research literature and government information is culled, information is corroborated and key market insights originate from interviews with industry leaders.

Product managers, marketing managers, business development executives, advertising agency or investment firm executives, and information and research center librarians are among the individuals who will find this report on the oral delivery drug market essential.

Global Drug Delivery Technology Industry

Chapter One: Executive Summary

Market Drivers

Market Size and Growth

Total Oral Drug Delivery Market

Oral Drug Delivery Technology Only Market

Competitive and Market Analysis

Chapter Two: Introduction and Overview

Scope of the Report

Methodology

History of Oral Drug Delivery

Phases of Drug Action

Barriers to Oral Drug Delivery

Controlled-Release/Sustained-Release

Delayed Release and Modified Release

Fast Dissolving

Taste-Masked

Pulsatile Release

Microemulsion and Others

Chapter Three: Key Trends and Demographics

The Elderly

Regulatory Environment

Patent Protection and Extension

Earlier Involvement

Consolidation

Proprietary Product Development

Implications for Generic and Over-the-Counter Products

Pharmaceutical Formulation

Chapter Four: New Developments

Macromolecule Delivery

Delivery of Hydrophobic Drugs

Other Delivery Solutions

Chapter Five: Market Size and Growth

The Total Oral Drug Delivery Market

Oral Delivery Technology Only Market

Chapter Six: Competitive Analysis

Competitive Landscape

Chapter Seven: Company Profiles

ALZA Corporation

Biovail Corporation

Elan Corporation, plc

Emisphere Technologies, Inc.

Ethypharm

KV Pharmaceutical

Labopharm, Inc.

Penwest Pharmaceutical Company

Purdue/MundiPharma/Napp Group

SkyePharma PLC

Watson Pharmaceuticals, Inc.

Chapter Eight: Companies in Brief

Alkermes, Inc.

Astellas Pharma US

CIMA Labs, Inc. Division of Cephalon

DepoMed, Inc.

Eurand, Inc.

Galenix

Intelgenx Technologies Corp

Kos Pharmaceuticals, Inc.

Lifecycle Pharma

MicroDose Therapeutics, Inc.

Scolr Pharma

Xcelience

Appendix: Company Directory

List of Exhibits

Chapter One: Executive Summary

Chapter Two: Introduction and Overview

Table 2-1: Selected Types of Oral Solid Preparations

Table 2-2: Sequence of Drug Action

Chapter Three: Key Trends and Demographics

Table 3-1: World Population by Age Group 2006-2013

Figure 3-1: World Population by Age Group 2006-2013

Table 3-2: Recent Consolidations in the Drug Delivery Market

Chapter Four: New Developments

Chapter Five: Market Size and Growth

Table 5-1: The Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals Revenues and Growth Rate 2006-2013

Figure 5-1: Trending in the Worldwide Market for Oral Drug Delivery Technology and Pharmaceuticals 2006-2013

Table 5-2: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type (Timed Release, Other) 2006-2013

Figure 5-2: Trending in the Worldwide Market for Pharmaceuticals Utilizing Oral Drug Delivery Technologies by Type (Timed Release, Other) 2006-2013

Table 5-3: The Worldwide Market for Pharmaceuticals Utilizing Oral Drug Market Share by Type 2006-2013

Table 5-4: The Worldwide Market for Oral Drug Delivery Systems by Pharmaceutical vs Drug Delivery Components 2006-2013

Table 5-5: The Worldwide Market for Oral Drug Delivery Systems Distribution of Revenue by Pharmaceutical vs Delivery Technology Components 2006-2013

Figure 5-3: The Worldwide Market for Oral Drug Delivery Systems Share of Revenue by Pharmaceutical vs. Delivery Technology Component 2006, 2010

Chapter Six: Competitive Analysis

Table 6-1: Leading Suppliers of Oral Drug Delivery Technology (Company, Proprietary Technology, Approved Products)